保留精囊的膀胱癌根治术可行且功能结果良好,不损害肿瘤学结局:一项纵向长期倾向匹配单中心研究
该单中心研究纳入2000至2017年470例根治性膀胱切除加原位回肠储尿囊患者,按神经与精囊保留状态分6组并倾向匹配。中位随访64个月,精囊保留组无局部复发生存差异(p=0.173),但无进展生存、癌症特异生存和总生存更优,勃起功能恢复比例更高且需助勃装置更少,日间尿控更佳。
要点
- 精囊保留根治性膀胱切除在高度选择患者中肿瘤学安全
- 精囊保留组无进展生存、癌症特异生存和总生存更优
- 精囊保留组勃起功能恢复更早更高且需助勃装置更少
核心结论
- 在高度选择患者中,精囊保留根治性膀胱切除肿瘤学安全,功能结局优异且更早达成并长期维持。
研究设计与样本
- 纵向长期倾向匹配单中心研究,纳入2000至2017年470例连续根治性膀胱切除加原位回肠储尿囊患者。
- 按术中尝试的神经与精囊保留状态分为6组:无保留55例、单侧神经保留159例、双侧神经保留132例、单侧精囊保留加单侧神经保留30例、单侧精囊保留加双侧神经保留45例、双侧精囊保留49例,并用倾向模型校正术前差异。
主要发现
- 全队列中位随访64个月,6组间局部无复发生存无差异(p=0.173)。
- 精囊保留根治性膀胱切除患者的无进展生存(p<0.001)、癌症特异生存(p=0.006)和总生存(p<0.001)更优。
- 精囊保留组在所有分析的所有时间点勃起功能恢复比例更高,双侧精囊保留者恢复更早。
- 精囊保留患者需助勃装置实现勃起和性交者显著更少。
- 整个期间日间尿控在精囊保留组显著更好(OR 2.64至5.21)。
临床怎么用
- 对高度选择的膀胱癌患者,可考虑精囊保留根治性膀胱切除以改善勃起功能和尿控且不损害肿瘤学结局。
局限性
- 研究为单中心、高度选择人群,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Seminal vesicle-sparing radical cystectomy has been reported to improve short-term functional results without compromising oncological outcomes. However, there is still a lack of data on long-term outcomes after seminal vesicle-sparing radical cystectomy. The aim of this study was to compare oncological and functional outcomes in patients after seminal vesicle-sparing vs nonseminal vesicle-sparing radical cystectomy. MATERIALS AND METHODS: Oncological and functional outcomes of 470 consecutive patients after radical cystectomy and orthotopic ileal reservoir from 2000 to 2017 were evaluated. They were stratified into 6 groups according to nerve-sparing and seminal vesicle-sparing status as attempted during surgery: no sparing at all (55), unilateral nerve sparing (159), bilateral nerve sparing (132), unilateral seminal vesicle-sparing and unilateral nerve sparing (30), unilateral seminal vesicle sparing and bilateral nerve sparing (45), and bilateral seminal vesicle sparing (49) and used propensity modeling to adjust for preoperative differences. RESULTS: Median followup among the entire cohort was 64 months. Among the 6 groups, our analysis showed no difference in local recurrence-free survival (p=0.173). However, progression-free, cancer-specific and overall survival were more favorable in patients with seminal vesicle-sparing radical cystectomy (p <0.001, p=0.006 and p <0.001, respectively). Proportions of patients with erectile function recovery were higher in the seminal vesicle-sparing groups at all time points in all analyses, respectively, with pronounced earlier recovery in patients with bilateral seminal vesicle sparing. Importantly, patients with seminal vesicle sparing were significantly less in need of erectile aids to achieve erection and intercourse. Over the whole period, daytime urinary-continence was significantly better in the seminal vesicle sparing groups (OR 2.64 to 5.21). CONCLUSIONS: In a highly selected group of patients, seminal vesicle sparing radical cystectomy is oncologically safe and results in excellent functional outcomes that are reached at an earlier time point after surgery and remain superior over a longer period of time.
引用
- Furrer MA, Kiss B, Studer UE, et al. Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center Study. J Urol. 2021. PMID: 33533638. doi:10.1097/JU.0000000000001635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。